Close
FINDING CURES TOGETHER<sup>SM</sup>

Media Advisories

 

 

AACR to Host Inaugural International Meeting on Advances in Malignant Lymphoma246026/11/2018 9:05:20 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx101False2018-06-11T20:45:00Z<div class="ExternalClass31104E45BF8A48C290E123D3BED1DB51"><p>​The American Association for Cancer Research (AACR) will host its <a href="http&#58;//link.email.dynect.net/link.php?DynEngagement=true&amp;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=http&#58;//www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID%3D147&amp;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=eXqEJl1NfqkXiU1xcA78JEtrwfT5VyAQJu5yuSpKUU8" target="_blank">Inaugural AACR International Meeting&#58; Advances in Malignant Lymphoma</a> later this month in Boston. Presented in cooperation with the International Conference on Malignant Lymphoma (ICML), this program will provide a forum for discussion and brainstorming about how recent advances and emerging areas of lymphoma research hold enormous potential for transforming clinical care.&#160;</p><p>The meeting is designed to be highly interactive and presents a unique opportunity to engage with international leaders in lymphoma research. Topics to be discussed include immunotherapy, targeted therapy, CRISPR screening, liquid biopsy, and studying canine lymphoma to develop treatments that will benefit dogs and humans.</p><p>The program will feature keynote addresses from renowned cancer researchers&#58;</p><p>On Friday, June 22, from 6-8 p.m. ET,<br><strong>•&#160;Michael Caligiuri, MD</strong>, City of Hope National Medical Center and Past President of the AACR, will present a talk titled “Immunogenicity Predicts Prevention,” and<br><strong>•&#160;Carl June, MD</strong>, University of Pennsylvania and member of the AACR Board of Directors, will present a talk titled “CAR T for Lymphoma and Beyond.”</p><p>On Tuesday, June 26, from 8-10 a.m. ET, <br><strong>•&#160;James Allison, PhD</strong>, The University of Texas MD Anderson Cancer Center, will present a talk titled “Immune Checkpoint Blockade in Cancer Therapy&#58; New Insights, Opportunities, and Prospects for Cures,” and <br><strong>•&#160;Kenneth Anderson, MD</strong>, Dana-Farber Cancer Institute, will present a talk titled “Targeting Achilles Heels in Multiple Myeloma.”</p><p>The keynote addresses will be available as webcasts within 24 hours of presentation.</p><p>Reporters may register for the meeting and complimentary access to the webcasts by contacting Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org">julia.gunther@aacr.org</a> or 215-446-6896.</p><p>To learn more about the meeting, watch <a href="http&#58;//link.email.dynect.net/link.php?DynEngagement=true&amp;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=https&#58;//youtu.be/TKHxV7cQe1Q&amp;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=ZMDBs2djYOigaMX66rLkc6JEDcFdvrMi5EOIDIWXSQc" target="_blank">this interview </a>with meeting chair Ari Melnick, MD. Visit the meeting website <a href="http&#58;//link.email.dynect.net/link.php?DynEngagement=true&amp;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=http&#58;//www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID%3D147%26DetailItemID%3D744&amp;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=wthwbsgE7FLyq7gz24JLqGhbUxu3MDq3-phTh2AFMUk">here</a>.</p><p><strong>WHEN&#58;</strong><br>June 22-26, 2018</p><p><strong>WHERE&#58;</strong><br>Boston Marriott Copley Place <br>110 Huntington Avenue<br>Boston, MA 02116</p><p><strong>PROGRAM&#58;</strong><br>Read the full program here.<br>Interviews can be arranged per the availability of the speakers.</p></div>
FDA, AACR, and SGO to Present Workshop on Gynecologic Malignancies113526/5/2018 6:07:04 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx100False2018-06-05T17:00:00Z<div class="ExternalClass3923E7A76C934267A0A70986525FE4DE"><p>​The U.S. Food and Drug Administration (FDA), the American Association for Cancer Research (AACR), and the Society of Gynecologic Oncology (SGO) present a workshop on drug development in gynecologic malignancies, a major cause of morbidity and mortality in the United States. </p><p>This workshop is designed to facilitate open discussion between the FDA, clinicians, laboratory experts, researchers, and patients on the way forward for diagnosis and treatment of gynecologic malignancies. Sessions will focus on immunotherapy, biomarkers, and novel study designs for rare subtypes.</p><p><strong>WHEN&#58;</strong><br>Thursday, June 14<br>8 a.m.-5 p.m. ET<br>In-person or live stream attendance is free but advance registration is requested. RSVP to Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org">julia.gunther@aacr.org</a> or 215-446-6896.</p><p><strong>WHERE&#58;</strong><br>FDA White Oak Campus<br>Great Room A<br>10903 New Hampshire Avenue<br>Silver Spring, MD 20993</p><p><strong>Transportation to FDA&#58;</strong> Information about public meetings at White Oak, including directions and parking, can be found here. Please allow time to locate parking (parking map), use the shuttle to Building 1, go through routine security procedures, and sign in. All visitors should park in Northwest Surface Lot 1, 3, or 4.</p><p><strong>SPEAKERS AND PROGRAM&#58;</strong><br>Interviews can be arranged per the availability of the speakers.</p><p><strong>Workshop Co-chairs&#58;</strong><br><strong>•&#160;FDA&#58;</strong><br><strong>•&#160;Sanjeeve Bala, MD, MPH</strong>, Clinical Team Leader Gynecologic Malignancies Group, Division of Oncology Products 1 (DOP1), Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research (CDER), FDA<br><strong>•&#160;Julia A. Beaver, MD</strong>, Director, Division of Oncology Products 1 (DOP1), Office of Hematology and Oncology Products (OHOP), Center for Drug Evaluation and Research (CDER), FDA<br><strong>•&#160;AACR</strong>&#58;<br><strong>•&#160;Deborah K. Armstrong, MD</strong>, Director, Breast and Ovarian Surveillance Service; Professor of Oncology, John Hopkins Kimmel Comprehensive Cancer Center<br><strong>•&#160;Gordon B. Mills, MD, PhD</strong>, Member, AACR Board of Directors; Co-Director, Zayed Institute for Personalized Cancer Therapy, Department of Systems Biology 1, Division of Cancer Medicine, UT MD Anderson Cancer Center<br><strong>•&#160;Society of Gynecologic Oncology (SGO)&#58;</strong><br><strong>•&#160;Rebecca Arend, MD</strong>, Assistant Professor of Obstetrics &amp; Gynecology, University of Alabama at Birmingham<br><strong>•&#160;Robert Coleman, MD, FACOG, FACS</strong>, Vice Chair, Clinical Research, Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Cancer Center<br><strong>•&#160;Thomas Herzog, MD</strong>, Deputy Director and Professor of Obstetrics &amp; Gynecology, University of Cincinnati Cancer Institute</p><p><strong>Program&#58;</strong><br><strong>8&#58;20–9&#58;55 a.m.&#58; </strong>Development of Immunotherapy in Gynecological Malignancies – Part 1</p><p><strong>10&#58;10–11&#58;55 a.m.&#58; </strong>Development of Immunotherapy in Gynecological Malignancies – Part 2</p><p><strong>1–2&#58;35 p.m.&#58;</strong> Biomarker Development and PARP Inhibitors</p><p><strong>2&#58;50–4&#58;35 p.m.&#58; </strong>Development of Drugs for Rare Gynecological Malignancies</p><p><a href="/AdvocacyPolicy/GovernmentAffairs/Documents/FDA%20AACR%20SGO%20Gyn%20Malignancies%20Workshop%20Agenda.pdf">Read </a>the full draft agenda.<br></p></div>
AACR Annual Meeting 2018 Science and Regulatory Policy Sessions242674/11/2018 6:40:50 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx99False2018-04-11T18:00:00Z<div class="ExternalClass3C1CE1652A3740EFAFE662D5DF7F0195"><p>​The American Association for Cancer Research (AACR) will be hosting its 109th Annual Meeting, April 14-18, 2018, at McCormick Place North/South in Chicago, bringing together more than 22,000 scientists, clinicians, advocates, and other attendees from around the world. In addition to a myriad of cancer research sessions, the AACR Annual Meeting will also feature a robust science policy and regulatory track. Key panel discussions are highlighted below&#58;</p><p><strong>The Cancer Survivorship Landscape&#58; Potential Focus Areas for the Future<br></strong>Sunday, April 15, 2018 | 5 – 6&#58;30 p.m.<br><em>Room W190 - McCormick Place West (Level 1) </em><br><strong>Anna D. Barker, PhD</strong> - Arizona State University, Scottsdale<br><strong>Greg J. Aune, MD, PhD</strong> - Children’s Cancer Research Institute, San Antonio<br><strong>Shelley Fuld Nasso, MPP</strong> - National Coalition for Cancer Survivorship, Silver Spring, Maryland <br><strong>Brenda M. Nevidjon, MSN, RN, FAAN</strong> - Oncology Nursing Society, Pittsburgh<br><strong>Julia H. Rowland, PhD</strong> - National Cancer Institute, Bethesda, Maryland <br><strong>Julie K. Silver, MD</strong> - Harvard Medical School, Boston<br><strong>Patty Spears</strong> - UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina<br><strong>Doug Ulman</strong> - Pelotonia, Columbus, Ohio</p><p><strong>A Town Hall Discussion of AACR’s Priorities in Tobacco Policy </strong><br>Monday, April 16, 2018 | 1 – 2&#58;45 p.m.<br><em>Room S401bcd - McCormick Place South (Level 4)</em><br><strong>Roy S. Herbst, MD, PhD (Chair)</strong> - Yale Cancer Center, New Haven, Connecticut <br><strong>Cathy L. Backinger, PhD, MPH</strong> – U.S. Food and Drug Administration, Silver Spring, Maryland<br><strong>Michele Bloch, MD, PhD</strong> - National Cancer Institute, Bethesda, Maryland <br><strong>Dorothy K. Hatsukami, PhD</strong> - University of Minnesota, Minneapolis<br><strong>Brian A. King, PhD, MPH</strong> - Centers for Disease Control and Prevention, Atlanta<br><strong>Christopher S. Lathan, MD, MS, MPH</strong> - Dana-Farber Cancer Institute, Boston</p><p><strong>NCI Director’s Address and Fireside Chat with AACR Leaders</strong><br>This session will be streamed via Facebook Live. Live stream can be accessed at <a href="http&#58;//facebook.com/aacr.org" target="_blank">http&#58;//facebook.com/aacr.org</a>. <br>Monday, April 16, 2018 | 3 – 3&#58;45 p.m.<br><em>Room W190 - McCormick Place West (Level 1) </em><br><strong>Norman E. Sharpless, MD</strong> - National Cancer Institute, Bethesda, Maryland <br><strong>Michael A. Caligiuri, MD</strong> – AACR President, City of Hope National Medical Center, Duarte, California <br><strong>Elizabeth M. Jaffee, MD</strong> – AACR President-Elect, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore</p><p><strong>Biden Cancer Initiative Colloquium</strong> <br>This session will be streamed via Periscope. Live stream can be accessed at <a href="http&#58;//twitter.com/aacr" target="_blank">http&#58;//twitter.com/aacr</a>. <br>Tuesday, April 17, 2018 5 – 6&#58;30 p.m.<br><em>Room S401bcd - McCormick Place South (Level 4)</em><br><strong>Elizabeth M. Jaffee, MD</strong> – AACR President-Elect, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore<br><strong>Gregory C. Simon, JD</strong> - Biden Cancer Initiative, Washington, D.C.<br><strong>Stanton L. Gerson, MD</strong> - Case Comprehensive Cancer Center, Cleveland<br><strong>Jay Holley </strong>- Uber Health, San Francisco<br><strong>Carla Tardif</strong> - Family Reach, Boston<br><strong>Louis J. DeGennaro, PhD</strong> - Leukemia &amp; Lymphoma Society, White Plains, New&#160;&#160;York <br><strong>&#160;Patricia M. Doykos, PhD</strong> - Bristol-Myers Squibb Foundation, New York<br><strong>&#160;Asif Dhar, MD, MBA</strong> - Deloitte Consulting, Washington, D.C.&#160; </p><p><br>&#160;</p></div>
AACR Announces Press Conference Schedule for Annual Meeting 2018 in Chicago74222/7/2018 6:29:52 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx98False2018-02-07T05:00:00Z<div class="ExternalClassB48B2088D7A349F4A2167D3F2CC9DD7A"><p>​The American Association for Cancer Research (AACR) will be hosting its 109th <a href="http&#58;//media.ne.cision.com/l/tmfpafly/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136" target="_blank">Annual Meeting</a>, April 14-18, 2018, at McCormick Place North/South in Chicago, Illinois. </p><p>The official AACR Annual Meeting press program will feature high-impact science that strengthens our understanding of cancer, as well as clinical trial results that highlight new treatment options and promise for cancer patients. </p><p>The press program will include three press conferences at the following times&#58;</p><p>•&#160;Sunday, April 15, 8&#58;30 a.m. CT<br>•&#160;Monday, April 16, 8&#58;30 a.m. CT<br>•&#160;Tuesday, April 17, 8&#58;30 a.m. CT</p><p>A call-in number will be available for reporters who cannot travel to Chicago. The press conference presentations will be announced closer to the meeting.</p><p>The press room will be open&#58; </p><p>•&#160;Saturday, April 14, 8 a.m.-6 p.m. CT<br>•&#160;Sunday, April 15-Tuesday, April 17, 7&#58;30 a.m.-6 p.m. CT<br>•&#160;Wednesday, April 18, 7&#58;30 a.m.-12 p.m. CT</p><p>Registration is complimentary for credentialed news media. Members of the media can register by contacting Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org" target="_blank">julia.gunther@aacr.org</a> or 215-446-6896. Reporters planning to cover remotely should contact Julia Gunther as well so that they receive all relevant communications sent before and during the meeting.</p><p>Public information officers at medical institutes and cancer centers (limit two PIOs per institution) can also register by contacting Julia Gunther.</p><p>To make a hotel reservation, visit the AACR’s housing site at <a href="https&#58;//www5.cmrhousing.com/aacr2018/Housing/ResHotel" target="_blank">https&#58;//www5.cmrhousing.com/aacr2018/Housing/ResHotel</a>. We recommend adding your name to the waitlist as soon as possible. We are currently on track to accommodate waitlist requests within the next month. </p><p>The AACR Annual Meeting has an anticipated attendance of more than 22,000 scientists, clinicians, advocates, and other attendees from around the world. With this year’s theme, “Driving Innovative Cancer Science to Patient Care,” the scientific program includes an outstanding roster of world-class speakers, hundreds of invited talks, and more than 6,000 proffered papers. Presentations at the AACR Annual Meeting will span the entire field of cancer research, highlighting basic, translational, and clinical research on important topics such as immunotherapy, targeted therapy, artificial intelligence, liquid biopsy, early detection, cancer interception, prevention, and survivorship. This year’s meeting also features a robust science policy and regulatory track as well as new cancer health disparities sessions. </p><p>View the meeting program <a href="http&#58;//media.ne.cision.com/l/tmfpafly/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136&amp;DetailItemID=711" target="_blank">here</a>. Those following on social media can join the conversation on Twitter at #AACR18.</p><p>This year’s press program will be managed by Julia Gunther, assistant director, media and public relations, <a href="mailto&#58;julia.gunther@aacr.org" target="_blank">julia.gunther@aacr.org</a> or 215-446-6896; Rachel Salis-Silverman, director, public relations, <a href="mailto&#58;rachel.silverman@aacr.org" target="_blank">rachel.silverman@aacr.org</a> or 215-446-7159; and Rick Buck, senior director, communications and public relations, <a href="mailto&#58;rick.buck@aacr.org" target="_blank">rick.buck@aacr.org</a> or 215-446-7162.</p></div>
American Association for Cancer Research to Host 2018 Annual Meeting in Chicago, April 14-1874211/25/2018 6:37:52 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx97False2018-01-22T19:30:00Z<div class="ExternalClass619D17FB3B124C35AE723BC4783FE58B"><p>The American Association for Cancer Research (AACR) will be hosting its 109th <a href="http&#58;//media.ne.cision.com/l/kyfwfegz/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136">Annual Meeting</a>, April 14-18, 2018, at McCormick Place North/South in Chicago, Illinois. </p><p>The AACR Annual Meeting has an anticipated attendance of more than 22,000 scientists, clinicians, advocates, and other attendees from around the world. With this year's theme, &quot;Driving Innovative Cancer Science to Patient Care,&quot; the scientific program includes an outstanding roster of world-class speakers, hundreds of invited talks, and more than 6,000 proffered papers. Presentations at the AACR Annual Meeting will span the entire field of cancer research, highlighting basic, translational, and clinical research on important topics such as immunotherapy, targeted therapy, artificial intelligence, liquid biopsy, early detection, cancer interception, prevention, and survivorship. This year's meeting also features a robust science policy and regulatory track as well as new cancer health disparities sessions. </p><p>The AACR press program will feature high-impact science that strengthens our understanding of cancer, as well as clinical trial results that highlight new treatment options and promise for cancer patients. The press conference schedule will be released in the next few weeks.</p><p><a href="http&#58;//media.ne.cision.com/l/kyfwfegz/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136&amp;DetailItemID=711" target="_blank">View the meeting program</a>. </p><p>Registration is complimentary for credentialed news media. Members of the media can register by contacting Julia Gunther at julia.gunther@aacr.org or 215-446-6896. Hotel information can be found on the AACR's <a href="http&#58;//media.ne.cision.com/l/kyfwfegz/www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136&amp;DetailItemID=710" target="_blank">website</a>. </p><p>Reporters planning to cover remotely should register so that they receive all relevant communications sent out by the AACR Department of Communications and Public Relations before and during the meeting.</p><p>Public information officers at medical institutes and cancer centers (limit two PIOs per institution) can also register by contacting Julia Gunther.</p><p>Those following on social media can join the conversation on Twitter at <a href="http&#58;//media.ne.cision.com/l/kyfwfegz/www.twitter.com/hashtag/aacr18" target="_blank">#AACR18</a>.</p><p>This year's press program will be managed by Julia Gunther, assistant director, media and public relations, julia.gunther@aacr.org or 215-446-6896; Rachel Salis-Silverman, director, public relations, rachel.silverman@aacr.org or 215-446-7159; and Rick Buck, senior director, communications and public relations, rick.buck@aacr.org or 215-446-7162.</p><p>&#160;</p></div>
On the AACR Blog: 2018 Cancer Research and Treatment Forecast74201/3/2018 4:23:03 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx96False2018-01-03T16:15:00Z<div class="ExternalClass7C4F045FD0F84DF48F7AEF860DC71E1A"><p>​PHILADELPHIA – <em><a href="http&#58;//blog.aacr.org/" target="_blank">Cancer Research Catalyst</a></em>, the official blog of the American Association for Cancer Research (AACR), today published a <a href="http&#58;//blog.aacr.org/experts-forecast-cancer-research-and-treatment-advances-in-2018/" target="_blank">post </a>highlighting perspectives from three distinguished AACR leaders who share where the cancer research community is headed and what major accomplishments we might expect in 2018.</p><p>In the post, AACR President-Elect Elizabeth M. Jaffee, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Andrea Califano, PhD, Columbia University Medical Center; and John Carpten, PhD, Keck School of Medicine at the University of Southern California, offer their predictions for cancer immunology, precision medicine, and prevention and disparities research, respectively.</p><p>Media are welcome to use excerpts and infographics from the post. Please link to the post <a href="http&#58;//blog.aacr.org/experts-forecast-cancer-research-and-treatment-advances-in-2018/" target="_blank">here </a>and cite the source&#58; “Originally posted on <em>Cancer Research Catalyst</em>, the official blog of the American Association for Cancer Research.”</p><p>This post is part of the ongoing mission of <em>Cancer Research Catalyst </em>to further accelerate the growth and spread of knowledge about cancer while providing helpful and interesting information to AACR members and the public. <br></p></div>
AACR Urges House-Senate Conference Committee for the Tax Cuts and Jobs Act to Remove Provisions Impacting Future Scientists, Cancer Patients, Survivors741912/13/2017 5:19:01 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx95False2017-12-13T17:00:00Z<div class="ExternalClass462BAE1F3591446584CD9C6CF89D27D9"><p>​PHILADELPHIA — The <a href="http&#58;//media.ne.cision.com/l/ydsazfey/www.aacr.org" target="_blank">American Association for Cancer Research </a>(AACR) on Tuesday delivered a letter to Rep. Kevin Brady (R-Texas), conference chair of the House-Senate Conference Committee for the Tax Cuts and Jobs Act, along with the other conferees, urging the committee to remove two provisions from the tax reform bill that, if enacted, would negatively impact cancer researchers and patients. The first would require that graduate student tuition waivers, which are currently tax-exempt, be reported as taxable income. The second would repeal the medical expense deduction.</p><p>The AACR’s membership consists of 40,000 members across the world. Of those, 13,000 are graduate students, medical students and residents, and clinical and postdoctoral fellows who are enrolled in educational or training programs leading to careers in cancer research. The House version of the tax reform legislation would effectively penalize these future scientists by taxing them on “income” they do not receive and would significantly increase their tax liability. We must continue to nurture and support a growing talent pool of future researchers and physician-scientists if we are to continue making progress against cancer.</p><p>In addition, millions of Americans with life-threatening, costly conditions and diseases, including many cancers, would no longer be able to receive financial relief from a medical expense tax deduction if their medical expenses exceed a certain percentage of their income. The AACR’s membership also includes patient advocates and cancer survivors, and its mission is focused in many ways on supporting the concerns and issues that they face. Therefore, the AACR opposes the repeal of the medical expense deduction.</p><p>The Senate version of the tax reform legislation did not include these two provisions, and the AACR is urging the conferees to support the Senate’s position and remove these two provisions from the final bill.</p><p>Read the full letter <a href="/AdvocacyPolicy/GovernmentAffairs/Documents/AACR%20HR1%20Letter%20Dec%202017.pdf" target="_blank">here</a>. </p></div>
Cancer Today Fall Issue Addresses Pediatric Cancer 74189/29/2017 4:53:01 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx94False2017-09-29T16:00:00Z<div class="ExternalClass9A4E5088738C40C1955215D4F5594A44"><p>​PHILADELPHIA — The Fall 2017 issue of <em><a href="http&#58;//www.cancertodaymag.org/Pages/default.aspx">Cancer Today</a></em>, a publication of the <a href="/">American Association for Cancer Research </a>(AACR), features “<a href="http&#58;//www.cancertodaymag.org/Fall2017/Pages/Challenges-Remain-For-Kids-With-Cancer.aspx">Challenges Remain for Kids With Cancer</a>.” Advances in pediatric cancer treatments are rightly touted as a success story, but some children’s cancer remains resistant to treatment. New therapies are being developed to help these children.</p><p>Published quarterly by the AACR, Cancer Today is an authoritative resource for cancer patients, survivors, and their family members and friends. In every issue, Cancer Today offers information and inspiration to help readers face the challenges of diagnosis, treatment, survivorship, and caregiving. </p><p>This issue of Cancer Today also includes “<a href="http&#58;//www.cancertodaymag.org/Fall2017/Pages/Fearless-Friends.aspx">Fearless Friends</a>,” a profile of the friendship and research advocacy collaboration of AnneMarie Ciccarella and the late Lori Marx-Rubiner. “<a href="http&#58;//www.cancertodaymag.org/Fall2017/Pages/Vaccines-Looking-Within-for-Cancer-Treament.aspx">Vaccines&#58; Looking Within for Treatment</a>” describes efforts to develop vaccines intended as treatment for cancer. “<a href="http&#58;//www.cancertodaymag.org/Fall2017/Pages/Cancer-Control-in-the-Community.aspx">Cancer Control in the Community</a>” discusses public health campaigns to prevent, detect, and treat cancer.</p><p>To read these stories and others, go to <a href="http&#58;//www.cancertodaymag.org/"><em>Cancer Today</em></a>, or follow the magazine on Facebook at <a href="https&#58;//www.facebook.com/CancerToday">facebook.com/CancerToday </a>and Twitter at <a href="https&#58;//twitter.com/CancerTodayMag">twitter.com/CancerTodayMag</a>. </p><p>Media are welcome to use information from <em>Cancer Today</em>; however, we ask that you cite the source.</p></div>
Leading Cancer Research Organizations to Host International Conference on Molecular Targets and Cancer Therapeutics in Philadelphia, Oct. 26-3074179/21/2017 4:56:30 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx93False2017-09-21T16:00:00Z<div class="ExternalClassAF09F8644CD54B40806BC195F535E158"><p>PHILADELPHIA — The American Association for Cancer Research (AACR), the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer (EORTC) will host their annual <a href="/Meetings/Pages/MeetingDetail.aspx?EventItemID=113#.WcGIpciGOUk">International Conference on Molecular Targets and Cancer Therapeutics </a>Oct. 26-30 at the Pennsylvania Convention Center in Philadelphia.</p><p>The Molecular Targets and Cancer Therapeutics conference is the premier international meeting featuring novel cancer therapeutics. It will bring together academics, scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection, and the impact of new discoveries in molecular biology.</p><p>The full program is available <a href="/Meetings/Pages/MeetingDetail.aspx?EventItemID=113&amp;DetailItemID=680">here</a>.</p><p>Registration is complimentary for credentialed news media and public information officers at medical institutes and cancer centers by contacting Lauren Riley at <a href="mailto&#58;lauren.riley@aacr.org">lauren.riley@aacr.org</a> or 215-446-7155.</p><p>Those following on social media can join the conversation on Twitter at <a href="https&#58;//twitter.com/search?f=realtime&amp;q=%23Targets17">#Targets17</a>.</p><p>For more information, contact Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org">julia.gunther@aacr.org</a> or 215-446-6896, or Lauren Riley at <a href="mailto&#58;lauren.riley@aacr.org">lauren.riley@aacr.org</a> or 215-446-7155.</p></div>
Leading Cancer Research Organizations to Host Cancer Immunotherapy Conference74168/16/2017 9:02:15 PMhttp://www.aacr.org/Newsroom/Lists/Media Advisories/AllItems.aspx92False2017-08-16T20:00:00Z<div class="ExternalClassDDB3A8AAD9404BAAAF416B7A2C619C68"><p>PHILADELPHIA – The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will sponsor the third <a href="http&#58;//www.cancerimmunotherapyconference.org/" target="_blank">International Cancer Immunotherapy Conference </a>at the Rheingoldhalle Congress Center in Mainz/Frankfurt, Germany, Sept. 6-9, 2017.</p><p>The program will focus on &quot;Translating Science into Survival,&quot; and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including neoantigens and vaccines, novel mechanisms of immunosuppression and immune evasion, biomarkers, microbiota, oncolytic viruses, new agents and their modes of action, combination therapies, adoptive cell therapies, new checkpoints, non-checkpoint immunotherapies, and the tumor microenvironment. </p><p>The full program is available <a href="http&#58;//www.cancerimmunotherapyconference.org/program-of-events">here</a>.</p><p>Registration is complimentary for credentialed news media. Members of the media can register by contacting Lauren Riley at <a href="mailto&#58;lauren.riley@aacr.org" target="_blank">lauren.riley@aacr.org</a> or 215-446-7155.</p><p>Public information officers at medical institutes and cancer centers can also register by contacting Lauren Riley.</p><p>For more information, contact Lauren Riley at <a href="mailto&#58;lauren.riley@aacr.org" target="_blank">lauren.riley@aacr.org</a> or 215-446-7155, or Julia Gunther at <a href="mailto&#58;julia.gunther@aacr.org" target="_blank">julia.gunther@aacr.org</a> or 215-446-6896.<br></p></div>